Tomohiro Yamaguchi, M.D., Ph.D.

Tomohiro Yamaguchi

Medical Reviewer
Office of Cellular and Tissue-based Products, Office of New Drugs V
Pharmaceuticals and Medical Devices Agency, Japan

Dr. Yamaguchi serves as a medical reviewer for the Office of Cellular and Tissue-based Products and the Office of New Drugs V at the Pharmaceuticals and Medical Devices Agency (PMDA).

As a medical reviewer with background in medical oncology and associated clinical trials, Dr. Yamaguchi is involved in the regulatory review and approval process for various oncology products in Japan and provides regulatory advice in clinical trial consultations for pharmaceutical companies and academic institutions. Prior to joining the PMDA, he worked at the National Cancer Center Hospital where he was involved in clinical trials, and at the Japan Clinical Oncology Group (JCOG) Data Center, where he served as a chief resident fellow supporting clinical trials on cancer.

Dr. Yamaguchi holds a Ph.D. in biostatistics from Yokohama City University and an M.D. from Tohoku University.